Jaundice during treatment of myelomatosis with M & B 938.
D000970:Antineoplastic Agents / Q000633:toxicity*; D004159:Diphenylamine / Q000031:analogs & derivatives; D006801:Humans; D007565:Jaundice / Q000209:etiology*; D009101:Multiple Myeloma / Q000628:therapy*; D010950:Plasma Cells
D000970:Antineoplastic Agents; C046869:4,4'-diamidinodiphenylamine; D004159:Diphenylamine
ANTINEOPLASTIC AGENTS/toxicology; JAUNDICE/etiology; MYELOMA, PLASMA CELL/therapy